Healthcare technology and Lifesciences M&A
Hemavli leads M&A advisory within healthcare and life sciences technology and specialist services including e-clinical solutions, medtech, software and IP driven consultancies.
She has spent the last 13 of her 17 year career in corporate finance, primarily providing M&A advice on deals in the healthcare tech and life sciences sectors, both in the UK and US. Her sector experience covers market access, healthcare communications, tech-enabled biopharma consultancy, CROs and other specialist outsourced biopharma services, patient engagement and healthcare technology. She is also active in medical device and pharma asset sales/divestments.
Learn more about Hemavli’s completed M&A deals.
Prior to joining Deloitte in 2015, Hemavli was an Executive Director at Results International where she co-led the formation of Results Healthcare before relocating to New York to establish a US office and lead the firm’s healthcare M&A operations in North America. Hemavli has also held roles at Nomura, Royal Bank of Canada and Ernst & Young. Hemavli is a Chartered Accountant and holds a BSc in Economics from the London School of Economics.